Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03379948
Other study ID # CAPVCABSIITCIPIAUH
Secondary ID
Status Not yet recruiting
Phase N/A
First received December 16, 2017
Last updated December 23, 2017
Start date February 1, 2018
Est. completion date February 1, 2020

Study information

Verified date December 2017
Source Assiut University
Contact mohamed maghraby, MD
Phone 01010685968
Email maghraby@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Catheter related infections (CRIs) were found to be associated with several risk factors, including patient related risk factors such as age, gender, clinical status and catheter related risk factors such as the vascular access location, dwelling time, catheter type and number of lumens. In addition to the inserted solution type and the experience of the professional who performs the procedure ,These factors constitute important strategic points for actions to compare the infectious complications of peripheral versus central venous catheters in critically ill patients.


Description:

Nosocomial (hospital-acquired) bloodstream infections (BSIs) are an important cause of morbidity and mortality, with an estimated 250,000 cases occurring each year in the United States.

BSIs may be either primary or secondary. Secondary infections are related to infections at other sites, such as the urinary tract, lung, postoperative wounds, and skin. Most nosocomial BSIs are primary, as illustrated by the United States Centers for Disease Control and Prevention's National Nosocomial Infection Surveillance system, in which 64 percent of the nosocomial BSIs reported were primary BSIs. While some primary BSIs have no identifiable source, most are associated with intravascular catheters, and central venous catheters (CVCs) in particular.

Critically ill patients require intravenous administration of fluids and drugs.This can be achieved via peripheral or central catheters. Each device is associated with both mechanical and infectious complications. Complications associated with central lines are judged to be more severe. Some patients actually require the insertion of a central line due to the venous toxicity of the drugs or to the necessity of making sure that the infusion is regularly administered (example: high dose catecholamine infusion). Some physicians believe that most Intensive Care Unit (ICU) patients should have a central venous line inserted, whereas others feel that some patients may receive active drugs via a peripheral line in selected instances.

Endpoints are the rate of mechanical complications (difficulty in inserting the line, need for repeat insertion attempts, occurrence of arterial puncture, occurrence of pneumothorax) and of infectious complications (local catheter infection or catheter-related bloodstream infection).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date February 1, 2020
Est. primary completion date February 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- All patient at ICU Diagnosed nosocomial infection

Exclusion Criteria:

- Patients exist already infected before admission at hospital.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
blood culture
blood culture to diagnose blood stream infection

Locations

Country Name City State
Egypt Assiut Universtay Hospital Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (4)

Chen HS, Wang FD, Lin M, Lin YC, Huang LJ, Liu CY. Risk factors for central venous catheter-related infections in general surgery. J Microbiol Immunol Infect. 2006 Jun;39(3):231-6. — View Citation

Holton D, Paton S, Conly J, Embree J, Taylor G, Thompson W. Central venous catheter-associated bloodstream infections occurring in Canadian intensive care units: A six-month cohort study. Can J Infect Dis Med Microbiol. 2006 May;17(3):169-76. — View Citation

Lorente L, Henry C, Martín MM, Jiménez A, Mora ML. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Crit Care. 2005;9(6):R631-5. Epub 2005 Sep 28. — View Citation

Timsit JF. [Updating of the 12th consensus conference of the Société de Réanimation de langue française (SRLF): catheter related infections in the intensive care unit]. Ann Fr Anesth Reanim. 2005 Mar;24(3):315-22. Review. French. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary compare the infectious complications of peripheral versus central venous catheters in critically ill patients by blood sample 7 days
See also
  Status Clinical Trial Phase
Completed NCT01597973 - Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME) Phase 3
Active, not recruiting NCT02743585 - Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT) N/A
Completed NCT01396642 - Topical Emollient Therapy N/A
Completed NCT02682355 - Optimizing Clinical Use of Polymyxin B
Completed NCT03284398 - Three-Chamber Bags Retrospective Study in Spain
Recruiting NCT05016752 - Application of Nanopore Sequencing in Newly Diagnosed Acute Myeloid Leukemia Patients With Bloodstream Infection